Cell signaling and trafficking of human melanocortin receptors in real time using two-photon fluorescence and confocal laser microscopy: Differentiation of agonists and antagonists

Chemical Biology and Drug Design

Volumn 68, Issue 4, 2006, Pages 183-193

  Cai, Minying ^a   Varga, Eva V ^b   Stankova, Magda ^a   Mayorov, Alexander ^a   Perry, Joseph W ^a,c   Yamamura, Henry I ^b   Trivedi, Dev ^a   Hruby, Victor J ^a  

^a University of Arizona   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

arrestin; Green fluorescence protein; Melanocortin receptors; MTII; Rhodamine; SHU 9119; Two photon fluorescence laser scanning microscopy

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BETA ARRESTIN; BETA ARRESTIN 2; CLATHRIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; GREEN FLUORESCENT PROTEIN; MELANOCORTIN RECEPTOR; RECEPTOR BLOCKING AGENT;

ARTICLE; CAVEOLA; CELL MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; WILD TYPE;

ALPHA-MSH; ARRESTINS; BINDING, COMPETITIVE; BIOLOGICAL TRANSPORT; CAVEOLAE; CELL LINE; CLATHRIN-COATED VESICLES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FORSKOLIN; GREEN FLUORESCENT PROTEINS; HUMANS; ISOQUINOLINES; KINETICS; MELANOCYTE-STIMULATING HORMONES; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; MODELS, MOLECULAR; PEPTIDES, CYCLIC; RECEPTORS, MELANOCORTIN; RHODAMINES; SIGNAL TRANSDUCTION; SULFONAMIDES; TRANSFECTION;

EID: 33751048740     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2006.00432.x     Document Type: Article

References (58)

1. Cone R.D. (2000) The Melanocortin Receptors. Totowa, New Jersey: Humana Press.
2. Starowicz K., Przewlocka B. (2003) The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception. Life Sci;73:823-847.
3. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. (1992) The cloning of a family of genes that encode the melanocortin receptors. Science;257:1248-1251.
4. Xia Y., Skoog V., Muceniece R., Chhajlani V., Wikberg J.E. (1995) Polyclonal antibodies against human melanocortin MC1 receptor: preliminary immunohistochemical localisation of melanocortin MC1 receptor to malignant melanoma cells. Eur J Pharmacol;288:277-283.
5. Li S.J., Varga K., Archer P., Hruby V.J., Sharma S.D., Kesterson R.A., Cone R.D., Kunos G. (1996) Melanocortin antagonists define two distinct pathways of cardiovascular control by α- and γ-melanocyte-stimulating hormones. Neuroscience;16:5182-5188.
6. Hagan M.M., Rushing P.A., Schwartz M.W., Yagaloff K.A., Burn P., Woods S.C. (1999) Role of the CNS melanocortin system in the response to overfeeding. J Neurol Sci;19:2362-2367.
7. Cone R.D. (1999) The central melanocortin system and its role in energy homeostasis. Ann Endocrinol;60:3-9.
8. Tritos N.A., Maratos-Flier E. (1999) Two important systems in energy homeostasis: melanocortins and melanin-concentrating hormone. Neuropeptides;33:339-349.
9. Gantz I., Fong T.M. (2003) The Melanocortin System. Am J Physiol;284:E468-E474.
10. Wessells H., Fuciarelli K., Hansen J., Hadley M.E., Hruby V.J., Dorr R., Levine N. (1998) Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J Urol;160:389-393.
11. Van der Ploeg L.H.T., Martin W.J., Howard A.D., Nargund R.P., Austin C.P., Guan X., Drisko J. et al. (2002) A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci U S A;99:11381-11386.
12. Hruby V.J., Cai M., Grieco P., Han G., Kavarana M., Trivedi D. (2003) Exploring the stereostructural requirements of peptide ligands for the melanocortin receptors. Ann N Y Acad Sci;994:12-20.
13. 111In]DTPA-labeled analogs of α-MSH for the detection of MSH receptors in vitro and in vivo. The melanotropic peptides. Ann N Y Acad Sci;680:1-687.
14. Hadley M.E. (1988) Source, Synthesis, Chemistry, Secretion, Circulation, and Metabolism. The Melanotropic Peptides, Vol. I-III. Boca Raton, FL: CRC Press.
15. Cone R.D. (2003) The Melanocortin System. Ann N Y Acad Sci;994:1-387.
16. Hughes S., Smith M.E., Bailey C.J. (1992) Beta-endorphin and corticotropin immunoreactivity and specific binding in the neuromuscular system of obese-diabetic mice. Neuroscience;48:463-468.
17. Chhajlani V. (1996) Distribution of cDNA of melanocortin receptor subtypes in human tissues. Biochem Mol Biol Int;38:73-80.
18. Raffin-Sanson M.L., Bertherat J. (2001) MC3 and MC4 receptors: complementary role in weight control. Eur J Endocrinol;144:207-208.
19. Abbott C.R., Rossi M., Kim M.S., Al Ahmed S.H., Taylor G.M., Ghatei M.A., Smith D.M., Bloom S.R. (2000) Investigation of the melanocyte stimulating hormones on food intake. Lack of evidence to support a role for the melanocortin-3-receptor. Brain Res;869:203-210.
20. Chen W.B., Kelly M.A., Opitz Araya X., Thomas R.E., Low M.J., Cone R.D. (1997) Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell;91:789-798.
21. Vergoni A.V., Bertolini A. (2000) Role of melanocortins in the central control of feeding. Eur J Pharmacol;405:25-32.
22. Chen A.S., Marsh D.J., Trumbauer M.E., Frazier E.G., Guan X.-M., Yu H., Rosenblum C.I. et al. (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet;26:97-102.
23. Clark R., Knoll B., Barber R. (1999) Partial agonists and G protein-coupled receptor desensitization. Trends Pharmacol Sci;20:279-286.
24. Cai M., Stankova M., Pond S.J.K., Mayorov A.V., Perry J.W., Yamamura H.I., Trivedi D., Hruby V.J. (2004) Real time differentiation of G-protein coupled receptor (GPCR) agonist and antagonist by two photon fluorescence laser microscopy. J Am Chem Soc;26:7160-7161.
25. Al-Obeidi F., Hadley M.E., Pettitt B.M., Hruby V.J. (1989) Design of a new class of superpotent cyclic α-melanotropins based on quenched dynamic simulations. J Am Chem Soc;111:3413-3416.
26. Hruby V.J., Lu D., Sharma S.D., Castrucci A., De L., Kesterson R.A., Al-Obeidi F.A., Hadley M.E., Cone R.D. (1995) Cyclic lactam α-melanotropin analogs of Ac-Nle4-cyclo[Asp5,D-Phe7,Lys10]-α-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J Med Chem;38:3454-3461.
27. Xu C., Webb, W. (1997) In: Lakowicz J., editor. Nonlinear and Two-Photon Induced Fluorescence, Vol. 5. New York: Plenum Press;p. 471-541.
28. Shenoy S.K., Lefkowitz R.J. (2003) Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signaling. Biochem J;375:503-515.
29. Lefkowitz R.J. (1998) G protein-coupled receptors: III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J Biol Chem;273:18677-18680.
30. Gurevich V.V., Dion S.B., Onorato J.J., Ptasienske J., Kim C.M., Sterne-Marr M., Hosey J.M., Benovic J.L. (1995) Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsins, β2-adrenergic, and m2 muscarinic cholinergic receptors. J Biol Chem;270:720-731.
31. Hunyady L., Baukal A.J., Balla T., Catt K.J. (1994) Independence of type I angiotensin II receptor endocytosis from G protein coupling and signal transduction. J Biol Chem;269:24798-24804.
32. Hruby V.J., Meyer J.P. (1998) Chemical synthesis of peptides. In: Hecht S.N., editor. Bioorganic Chemistry: Peptides and Protein. New York, USA: Oxford University Press;p. 27-64.
33. Grieco P., Gitu P.M., Hruby V.J. (2001) Preparation of 'sidechain-to-side-chain' cyclic peptides by allyl and alloc strategy: potential for library synthesis. J Pept Res;57:250-256.
34. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., Delvalle J., Yamada T. (1993) Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem;268:15174-15179.
35. Cai M., Mayorov A.V., Cabello C., Stankova M., Trivedi D., Hruby V.J. (2005) Novel 3D pharmacophore of α-MSH/γ-MSH hybrids leads to selective human MC1R and MC3R analogues. J Med Chem;48:1839-1848.
36. Baig A.H., Swords F.M., Szaszak J., King P.J., Hunyady L., Clark A.J.L. (2002) Agonist activated adrenocorticotropin receptor internalizes via a clathrin-mediated G protein receptor kinase dependent mechanism. Endocr Res;28:281-289.
37. Cai M., Cai C., Mayorov A.V., Xiong C., Cabello C.M., Soloshonok V.A., Swift J.R., Trivedi D., Hruby V.J. (2004) Biological and conformational study of β-substituted prolines in MT-II template: steric effects leading to human MC5 receptor selectivity. J Pept Res;63:116-131.
38. Kolossváry I., Keserü G.M. (2001) Hessian-free low-mode conformational search for large-scale protein loop optimization: application to C-Jun N-terminal kinase JNK3. J Comput Chem;22:21-30.
39. Parish C., Lombardi R., Sinclair K., Smith E., Goldberg A. (2002) A comparison of the Low Mode and Monte Carlo conformational search methods. J Mol Graph Model;21:129-150.
40. Greenidge P.A., Merette S.A.M., Beck R., Dodson G., Goodwin C.A., Scully M.F., Spencer J., Weiser J., Deadman J.J. (2003) Generation of ligand conformations in continuum solvent consistent with protein active site topology: application to thrombin. J Med Chem;46:1293-1305.
41. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature;385:165-168.
42. Li S.J., Varga K., Archer P., Hruby V.J., Sharma S.D., Kesterson R.A., Cone R.D., Kunos G. (1996) Melanocortin antagonists define two distinct pathways of cardiovascular control by α- and γ-melanocyte-stimulating hormones. J Neurosci;16:5182-5188.
43. Gao Z., Lei D., Welch J., Le K., Lin J., Feng S., Duhl D. (2003) Agonist-dependent internalization of the human melanocortin-4 receptors in human embryonic kidney 293 cells. J Pharm Exp Ther;307:870-877.
44. Lohse M., Benovic J., Codina J., Caron M., Lefkowitz R.J. (1990) beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science;248:1547-1550.
45. Pierce K., Lefkowitz R.J. (2001) Classical and new roles of β-arrestins in the regulation of G-protein-coupled receptors. Nat Rev Neurosci;2:727-733.
46. Zhang J., Barak L.S., Winkler K.E., Caron M.G., Ferguson S.S.G. (1997) A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. J Biol Chem;272:27005- 27014.
47. Oakley R.H., Laporte S.A., Holt J.A., Barak L.S., Caron M.G. (1999) Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J Biol Chem;274:32248-32257.
48. Tsao P.I., von Zastrow M. (2001) Diversity and specificity in the regulated endocytic membrane trafficking of G-protein-coupled receptors. Pharmacol Ther;89:139-147.
49. Claing A., Laporte S.A., Caron M.G., Lefkowitz R.J. (2002) Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and β-arrestin proteins. Prog Neurobiol;66:61-79.
50. Menard L., Ferguson S.S.G., Zhang J., Lin F.T., Lefkowitz R.J., Caron M.G., Barak L.S. (1997) Synergistic regulation of β2-adrenergic receptor sequestration: intracellular complement of β-adrenergic receptor kinase and β-arrestin determine kinetics of internalization. Mol Pharmacol;51:800- 808.
51. Krupnick J.G., Santini F., Gagnon A.W., Keen J.H., Benovic J.L. (1997) Modulation of the arrestin-clathrin interaction in cells. Characterization of β-arrestin dominant-negative mutants. J Biol Chem;272:32507-32512.
52. Pitcher J.A., Freedman N.J., Lefkowitz R.J. (1998) G protein-coupled receptor kinases. Ann Rev Biochem;67:653-692.
53. Nakamura K., Krupnick J.G., Benovic J.L., Asoli M. (1998) Signaling and phosphorylation-impaired mutants of the rat follitropin receptor reveal an activation- and phosphorylation-independent but arrestin-dependent pathway for internalization. J Biol Chem;273:24346-24354.
54. Dicker F., Quitterer U., Winstel R., Honold K., Lohse M.J. (1999) Phosphorylation-independent inhibition of parathyroid hormone receptor signaling by G protein-coupled receptor kinases. Proc Natl Acad Sci U S A;96:5476-5481.
55. Okamoto Y., Ninomiya H., Miwa S., Masaka T. (2000) Cholesterol oxidation switches the internalization pathway of endothelin receptor type A from caveolae to clathrin-coated pits in Chinese hamster ovary cells. J Biol Chem;275:6439-6446.
56. Schnitzer J.E., Oh P., Pinney E., Allard J. (1994) Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol;127:1217-1232.
57. Henley J.R., Krueger E.W., Oswald B.J., McNiven M.A. (1998) Dynamin-mediated internalization of caveolae. J Cell Biol;141:85-99.
58. Shinyama H., Masuzaki H., Fang H., Flier J.S. (2003) Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology;144:1301-1314.